Sol-Gel Technologies
SLGL • NASDAQ
Sol-Gel Technologies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Moshe Arkin, with a market cap of $222.5M.
Market Cap$222.5M
Employees36.0
CEOMoshe Arkin
CountryIsrael
Healthcare
Biotechnology
Next EarningsMay 22, 2026 · in a monthQ1 2026
Financials
SLG
Sol-Gel Technologies FAQ
Common questions about Sol-Gel Technologies
Sol-Gel Technologies is scheduled to report earnings for Q1 2026 on May 22, 2026. Analysts estimate revenue of $900.0K.
Sol-Gel Technologies has approximately 36 employees.